Posts Tagged ‘UVB Phototherapy’
Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study
Philadelphia, Pennsylvania; Los Angeles, California; Salt Lake City, Utah; Williamsville, New York; Dallas, Texas; Portland, Oregon; Norfolk, Virginia; and Bethesda, Maryland J AM ACAD DERMATOL OCTOBER 2019 Background: There are limited data about the impact of narrowband ultraviolet B phototherapy on patient-reported measures of health-related quality of life. Objective: To evaluate the impact of adalimumab…Read More
Ultralite phototherapy expands system services!
February 1, 2018 – Dacula, GA The leading manufacturer of clinical phototherapy in America, Ultralite Enterprises, has been making some big strides lately. In 2018 the company relocated in order to accommodate growth and expanded line extensions. After decades headquartered in Lawrenceville, GA, the company moved to a larger facility in nearby Dacula, GA. New…Read More
Narrowband UVB Phototherapy for the Treatment of Psoriasis
With approximately 150,000 newly diagnosed cases of psoriasis each year, this chronic skin disease affects approximately 2% of the US population and causes considerable morbidity.(1) First-stage treatment of patients with moderate- to-severe psoriasis often starts with topical agents and then progresses to phototherapy (UVB) for more extensive disease. Extensive disease that cannot be controlled adequately…Read More